Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells

Medroxyprogesterone Reverses Tolerable Dose Metformin-Induced Inhibition of Invasion via Matrix Metallopeptidase-9 and Transforming Growth Factor-β1 in KLE Endometrial Cancer Cells

This study was performed to evaluate the anticancer effects of tolerable doses of metformin with or without medroxyprogesterone (MPA) in endometrial cancer cells. Cell viability, cell invasion, and levels of matrix metallopeptidase (MMP) and transforming growth factor (TGF)-β1 were analyzed using th...

Full description

Bibliographic Details
Main Authors:	Dong Hoon Suh, Sunray Lee, Hyun-Sook Park, Noh Hyun Park
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Series:	Journal of Clinical Medicine
Subjects:	metformin medroxyprogesterone endometrial cancer invasion matrix metallopeptidase-9 transforming growth factor-β1
Online Access:	https://www.mdpi.com/2077-0383/9/11/3585

Similar Items

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
by: Fariba Behnamfar, et al.
Published: (2014-01-01)

Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells
by: Wenjiao Cao, et al.
Published: (2019-11-01)

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia
by: Toshiya Matsuzaki, et al.
Published: (2018-07-01)

Medroxyprogesterone to treat corneal thinning postcurvularia keratitis
by: Lubna Khan, et al.
Published: (2019-01-01)

Metallopeptidases of Toxoplasma gondii: in silico identification and gene expression
by: Escotte-Binet Sandie, et al.
Published: (2018-01-01)

PARTIAL PURIFICATION AND CHARACTERIZATION OF AN EXTRACELLULAR METALLOPEPTIDASE PRODUCED BY Bacillus amyloliquefaciens FE-K1
by: Muharrem Certel, et al.
Published: (2020-04-01)

The In Vitro Inhibitory Effect of Sivelestat on Elastase Induced Collagen and Metallopeptidase Expression in Equine Endometrium
by: Ana Amaral, et al.
Published: (2020-05-01)

Metformin as a Therapeutic Target in Endometrial Cancers
by: Teresa Y. Lee, et al.
Published: (2018-08-01)

Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
by: Yunxia Cui, et al.
Published: (2021-04-01)

The function of metformin in endometrial receptivity (ER) of patients with polycyclic ovary syndrome (PCOS): a systematic review and meta-analysis
by: Lifang Yuan, et al.
Published: (2021-06-01)

Structure-based mechanism of cysteine-switch latency and of catalysis by pappalysin-family metallopeptidases
by: Tibisay Guevara, et al.
Published: (2020-01-01)

Myeloperoxidase Inhibition Decreases the Expression of Collagen and Metallopeptidase in Mare Endometria under In Vitro Conditions
by: Ana Amaral, et al.
Published: (2021-01-01)

Effect of Matrix Metallopeptidase 13 on the Function of Mouse Bone Marrow-derived Dendritic Cells
by: Xiao-Dong Li, et al.
Published: (2017-01-01)

Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
by: Oroma Nwanodi
Published: (2017-07-01)

Effect of metformin use on the risk and prognosis of endometrial cancer: a systematic review and meta-analysis
by: Danxia Chu, et al.
Published: (2018-04-01)

The impact of the steroid hormones medroxyprogesterone acetate, cortisol and progesterone on protective immunity to tuberculosis
by: Kleynhans, Leanie
Published: (2012)

A novel mutation in the matrix metallopeptidase 2 coding gene associated with intrafamilial variability of multicentric osteolysis, nodulosis, and arthropathy
by: Liisa Kröger, et al.
Published: (2019-08-01)

The effect of medroxyprogesterone acetate on pregnancy rates in reindeer calves (Rangifer tarandus)
by: Erik Ropstad, et al.
Published: (1993-12-01)

Quantification of collagen fibers in canine uteri treated with medroxyprogesterone acetate
by: Paulo Salinas, et al.

Effect of medroxyprogesterone acetate on thyrotropin secretion in adult and old female rats
by: R.M. Moreira, et al.
Published: (2000-09-01)

Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?
by: Mandreker Bahall, et al.
Published: (2016-09-01)

Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report
by: Mitsutake Yano, et al.
Published: (2019-06-01)

Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
by: Sarah J. Kitson, et al.
Published: (2019-05-01)

Metformin sensitizes endometrial cancer cells to progestin by targeting TET1 to downregulate glyoxalase I expression
by: Yanyu Jiang, et al.
Published: (2019-05-01)

Metformin Dysregulates the Unfolded Protein Response and the WNT/β-Catenin Pathway in Endometrial Cancer Cells through an AMPK-Independent Mechanism
by: Domenico Conza, et al.
Published: (2021-04-01)

The potential for intramuscular depot medroxyprogesterone acetate as a self-bridging emergency contraceptive
by: Robyn Schickler, et al.
Published: (2021-01-01)

Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity
by: Xiangxu Jia, et al.
Published: (2021-09-01)

Sexual Dysfunction in Two Types of Hormonal Contraception: Combined Oral Contraceptives versus Depot Medroxyprogesterone Acetate
by: Nourossadat Kariman, et al.
Published: (2017-01-01)

Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus
by: Perez Lopez, Faustino R., et al.
Published: (2017)

Associations of Interleukin 10, Matrix Metallopeptidase 9, and Legumain with Blood Pressure Variability and Neurologic Outcomes in Patients with Ischemic Stroke
by: Rong T, et al.
Published: (2020-12-01)

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
by: Chengliang Yin, et al.
Published: (2020-08-01)

Dietary intake and eating behavior in depot medroxyprogesterone acetate users: a systematic review
by: P. Silva, et al.
Published: (2018-04-01)

Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo
by: Can Cao, et al.
Published: (2019-07-01)

Self-administered subcutaneous medroxyprogesterone acetate for improving contraceptive outcomes: a systematic review and meta-analysis
by: Ashraf Nabhan, et al.
Published: (2021-10-01)

Comparison of Dydrogesterone and Medroxyprogesterone in the Progestin-Primed Ovarian Stimulation Protocol for Patients With Poor Ovarian Response
by: Junwei Zhang, et al.
Published: (2021-09-01)

Characterization of a new M13 metallopeptidase from deep-sea Shewanella sp. E525-6 and mechanistic insight into its catalysis
by: Jin-Yu eYang, et al.
Published: (2016-01-01)

Comparative study of the molecular mechanism of action of the synthetic progestins, Medroxyprogesterone acetate and Norethisterone acetate
by: Africander, Donita Jean
Published: (2010)

Body composition, resting energy expenditure and inflammatory markers: impact in users of depot medroxyprogesterone acetate after 12 months follow-up
by: Gisele Almeida Batista, et al.
Published: (2016-09-01)

Downregulation of Cyclophilin A by siRNA diminishes non-small cell lung cancer cell growth and metastasis via the regulation of matrix metallopeptidase 9
by: Qian Zhe, et al.
Published: (2012-10-01)

The effect of the copper intrauterine device (Cu-IUD) and the injectable depo-medroxyprogesterone acetate (DMPA) use on women’s sexual satisfaction and depression
by: Samaneh Hagh-Mohammadi Pasanad, et al.
Published: (2020-01-01)